In this epiosde, Carol Wittlieb-Weber, MD, provides a cardiology-focused look at why vamorolone’s dissociative steroid profile and mineralocorticoid receptor antagonism may matter for cardiac fibrosis and remodeling in DMD.
Carol Wittlieb-Weber, MD
Advertisement
Articles by Carol Wittlieb-Weber, MD
Experts discuss Duchenne muscular dystrophy's pathophysiology, disease progression, and innovative treatment options to enhance patient care and outcomes.
Experts discuss Duchenne muscular dystrophy's pathophysiology, disease progression, and innovative treatment options to enhance patient care and outcomes.
Explore the evolving standard of care for Duchenne Muscular Dystrophy, focusing on corticosteroids and innovative treatment strategies.
Exploring the challenges faced by families of Duchenne muscular dystrophy patients, including caregiver burdens and the importance of timely diagnosis.
Advertisement
Latest Updated Articles
Evolution of Duchenne Muscular Dystrophy Management: From Traditional Therapies to Novel InterventionsPublished: January 14th 2025 | Updated:
- Caregiver Burden and Diagnostic Considerations in Duchenne Muscular Dystrophy
Published: January 14th 2025 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Secondary Analysis Finds Oveporexton Improves Cognitive Function in Adults With Narcolepsy Type 1
2
sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis
3
Rituximab Displays Long-Term Effectiveness for Relapsing MS
4
NeuroVoices: Nicholas Ashton, PhD, on Advances and Challenges in Alzheimer Disease Biomarkers
5